ALFA FinderBSE filing, NSE: DRAGARWQ. Summary written from the filing by ALFA Finder's alert engine.
Dr. Agarwal's Eye Hospital Ltd: key numbers
- Share price
- ₹5,392.50
- Market cap
- ₹2,534 Cr
- Revenue (annual)
- ₹470.9 Cr
- Net profit (annual)
- ₹70.10 Cr
- P/E (TTM)
- 33.2×Sector 53.9×
- Promoter holding
- 72.67%+0.00% QoQ
- FII holding
- 2.22%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dr. Agarwal's Eye Hospital Ltd
All →Dr. Agarwal's Eye Hospital Acquisition Worth ₹711.2 Cr
Dr. Agarwal's Eye Hospital Limited has completed its amalgamation with Dr. Agarwal's Health Care Limited, with the transaction valued at ₹711.21 Crore.
- Value
- ₹711.2 Cr
Dr. Agarwal's Eye Hospital Acquisition
Dr. Agarwal's Eye Hospital announced the effectiveness of its Scheme of Amalgamation starting November 01, 2026, and fixed a record date for share allotment.
Dr. Agarwal's Eye Hospital Other Announcement
The company submitted its quarterly shareholding pattern as mandated by SEBI. The filing provides a breakdown of shareholdings among promoters and the public.
Dr. Agarwal's Eye Hospital Acquisition
The NCLT Chennai Bench has sanctioned the Scheme of Amalgamation between Dr. Agarwal’s Eye Hospital Limited and Dr. Agarwal’s Health Care Limited. The company awaits the order copy.
Dr. Agarwal's Eye Hospital Annual General Meeting
Dr. Agarwal's Eye Hospital Limited held its 32nd Annual General Meeting on September 09, 2026. The meeting concluded with the approval of six business resolutions.
Dr. Agarwal's Eye Hospital Business Update
Dr. Agarwals Eye Hospital inaugurated its new Pinhole Pupilloplasty Centre in Chennai. This facility provides advanced specialized clinical treatments for patients with complex corneal conditions.
Other annual report announcements
All →Generic Engineering Construction and Projects Annual Report
Generic Engineering filed its FY2025-26 Annual Report ahead of its 32nd AGM on 30 November 2026. The filing covers board changes and a planned bank-funded EPC expansion.
Vineet Laboratories Annual Report
Vineet Laboratories filed its FY 2025-26 Annual Report, which marks its turnaround and recapitalisation year. The AGM is scheduled for 30 November 2026.
Indrayani Biotech Annual Report
Indrayani Biotech has filed its 34th Annual Report for FY2025-26, containing the AGM notice for 30 November 2026 by VC/OAVM. The chairman notes a Rights Issue was initiated in October 2026 to raise capital.
ESDS Software Solution Annual Report
ESDS Software Solution submitted its FY2025-26 Annual Report along with the AGM notice. The AGM is on 30 November 2026 via VC/OAVM, with remote e-voting.
The Orissa Minerals Development Company Annual Report
Orissa Minerals Development Company filed its FY 2025-26 Annual Report and 108th AGM notice, with the AGM set for 30 November 2026. The filing is a Regulation 34 intimation with no transaction or financial event.
Viksit Engineering Annual Report
Viksit Engineering filed its 44th Annual Report for FY 2025-26 with BSE. The report includes notice of the AGM on 30 November 2026.